LakeShore Biopharma Co., Ltd Financial Flexibility Index
LakeShore Biopharma Co., Ltd financial flexibility index. LakeShore Biopharma Co., Ltd (LSBCF) has a Financial Flexibility Index of -0.01x as of June 2022. Free cash flow of $-693.96K (operating CF $-693.96K minus capex $0.00) represents 0% of total liabilities ($76.38 Million). See LakeShore Biopharma Co., Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of LakeShore Biopharma Co., Ltd (2021–2025)
Financial flexibility index of LakeShore Biopharma Co., Ltd from 2021 to 2025. Historical Financial Flexibility Index trend for LakeShore Biopharma Co., Ltd across 5 annual periods. Check LakeShore Biopharma Co., Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
LakeShore Biopharma Co., Ltd Financial Flexibility Index by Year (2021–2025)
LakeShore Biopharma Co., Ltd financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for LakeShore Biopharma Co., Ltd. For the full cash flow conversion analysis, see LakeShore Biopharma Co., Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-103.12 Million | $-120.98 Million | $867.91 Million | ▲ +56.1% |
| 2024 | -0.27x | $-250.98 Million | $-295.23 Million | $927.82 Million | ▼ -113.8% |
| 2023 | -0.13x | $-125.42 Million | $-182.47 Million | $991.30 Million | ▼ -102.1% |
| 2022 | 6.16x | $125.39 Million | $-173.55 Million | $20.35 Million | ▲ +100.3% |
| 2021 | -2024.38x | $-141.73 Million | $-246.61 Million | $70.01K | — |